About Us

Founded in 2015 | Based in Bay Area, California

We are a California-based company located in the Bay Area and have been operational since December 2015. Our team brings together scientific expertise and operational excellence to advance research in Ophthalmology.

Our Mission

We are dedicated to improving the future of eye care by:

  • Diversifying therapeutic options for patients with ocular diseases

  • Reducing the probability of failure in ophthalmic clinical trials

  • Delivering results in a cost-effective and efficient manner

What We Do

We provide specialized research and operational support with a focus on:

  • Early-phase ophthalmic clinical trials, while maintaining the bandwidth to support Phase 3 (pivotal) trials

  • Drug repositioning strategies in partnership with biotech companies

  • Endpoint development and biomarker discovery

  • Customized approaches to enhance trial success and scientific impact

Collaborations

We have built strong relationships across the ophthalmology field, working together on:

  • Repositioning existing therapies for new ophthalmic indications

  • Designing and refining clinically meaningful endpoints

  • Identifying biomarkers that improve decision-making in clinical development